Countouriotis Athena

President & CEO at Turning Point Therapeutics, Inc.

Sold, on record
$8.4M
Dollars the filings state
Form 4 sales
2
Latest Feb 9, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Feb 11, 2021 2021

    Sold 60,000 shares at $137.48 ($8.2M)

    Countouriotis Athena, President & CEO

    Sold 54.4% of holdings ($15.2M position)50,195 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    Feb 9, 2022 +363 days

    Sold 2,971 shares at $36.30 ($108k)

    Countouriotis Athena, President & CEO

    Sold 5.8% of holdings ($1.8M position)47,930 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Countouriotis Athena
Source
Feb 9, 2022Feb 11, 2022Turning Point Therapeutics, Inc.President & CEOForm 4 sale2,971$108k5.8%Plan not statedSEC
Feb 11, 2021Feb 11, 2021Turning Point Therapeutics, Inc.President & CEOForm 4 sale60,000$8.2M54.4%UnusualSEC